Study of Vaccine-Elicited HIV-1 Fusion Peptide-Targeting Antibody

被引：0

作者：

Xu, Kai ^{[1
]}

Liu, Kevin ^{[1
]}

Acharya, Priyamvada ^{[1
]}

Kong, Rui ^{[1
]}

Druz, Alex ^{[1
]}

Carragher, Bridget ^{[2
]}

Potter, Clinton S. ^{[2
]}

Mascola, John R. ^{[1
]}

Kwong, Peter D. ^{[1
]}

机构：

[1] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[2] Simons Electron Microscopy Ctr, Natl Resource Automated Mol Microscopy, New York, NY USA

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 2016年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P19.55LB

引用

页码：349 / 349

页数：1

共 50 条

[31] Targeting the HIV-1 Env fusion protein
Du Toit, Andrea
NATURE REVIEWS MICROBIOLOGY, 2024, 22 (03) : 120 - 120
[32] Targeting the HIV-1 Env fusion protein
Andrea Du Toit
Nature Reviews Microbiology, 2024, 22 : 120 - 120
[33] Membrane topology of the HIV-1 fusion peptide
Nieva, JL
Agirre, A
Suárez, T
Goñi, FM
SPECTROSCOPY OF BIOLOGICAL MOLECULES: NEW DIRECTIONS, 1999, : 381 - 382
[34] An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
van Gils, Marit J.
van den Kerkhof, Tom L. G. M.
Ozorowski, Gabriel
Cottrell, Christopher A.
Sok, Devin
Pauthner, Matthias
Pallesen, Jesper
de Val, Natalia
Yasmeen, Anila
de Taeye, Steven W.
Schorcht, Anna
Gumbs, Stephanie
Johanna, Inez
Saye-Francisco, Karen
Liang, Chi-Hui
Landais, Elise
Nie, Xiaoyan
Pritchard, Laura K.
Crispin, Max
Kelsoe, Garnett
Wilson, Ian A.
Schuitemaker, Hanneke
Klasse, Per Johan
Moore, John P.
Burton, Dennis R.
Ward, Andrew B.
Sanders, Rogier W.
NATURE MICROBIOLOGY, 2017, 2 (02):
[35] An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Marit J. van Gils
Tom L. G. M. van den Kerkhof
Gabriel Ozorowski
Christopher A. Cottrell
Devin Sok
Matthias Pauthner
Jesper Pallesen
Natalia de Val
Anila Yasmeen
Steven W. de Taeye
Anna Schorcht
Stephanie Gumbs
Inez Johanna
Karen Saye-Francisco
Chi-Hui Liang
Elise Landais
Xiaoyan Nie
Laura K. Pritchard
Max Crispin
Garnett Kelsoe
Ian A. Wilson
Hanneke Schuitemaker
Per Johan Klasse
John P. Moore
Dennis R. Burton
Andrew B. Ward
Rogier W. Sanders
Nature Microbiology, 2
[36] Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans
Xu, Shiwei
Carpenter, Margaret C.
Spreng, Rachel L.
Neidich, Scott D.
Sarkar, Sharanya
Tenney, DeAnna
Goodman, Derrick
Sawant, Sheetal
Jha, Shalini
Dunn, Brooke
McElrath, M. Juliana
Bekker, Valerie
Mudrak, Sarah, V
Flinko, Robin
Lewis, George K.
Ferrari, Guido
Tomaras, Georgia D.
Shen, Xiaoying
Ackerman, Margaret E.
NPJ VACCINES, 2022, 7 (01)
[37] Diversity of Antibody Germline Gene and HIV-1 Infection: Implication for HIV-1 Vaccine
Guan, Yongjun
Yu, Lei
Zhan, Ming
Gallo, Robert C.
Liu, Tongyun
Sajadi, Mohammad
DeVico, Anthony L.
Lewis, George K.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 : 53 - 53
[38] Structural Study of a New HIV-1 Entry Inhibitor and Interaction with the HIV-1 Fusion Peptide in Dodecylphosphocholine Micelles
Perez, Yolanda
Jose Gomara, Maria
Yuste, Eloisa
Gomez-Gutierrez, Patricia
Jesus Perez, Juan
Haro, Isabel
CHEMISTRY-A EUROPEAN JOURNAL, 2017, 23 (48) : 11703 - 11713
[39] Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans
Shiwei Xu
Margaret C. Carpenter
Rachel L. Spreng
Scott D. Neidich
Sharanya Sarkar
DeAnna Tenney
Derrick Goodman
Sheetal Sawant
Shalini Jha
Brooke Dunn
M. Juliana McElrath
Valerie Bekker
Sarah V. Mudrak
Robin Flinko
George K. Lewis
Guido Ferrari
Georgia D. Tomaras
Xiaoying Shen
Margaret E. Ackerman
npj Vaccines, 7
[40] Toward an Antibody-Based HIV-1 Vaccine
Hoxie, James A.
ANNUAL REVIEW OF MEDICINE, 2010, 61 : 135 - 152

← 1 2 3 4 5 →